Curaleaf Pharmacy
Curaleaf Pharmacy is a GPhC-registered online pharmacy dispensing private medical cannabis prescriptions to UK and Channel Islands patients, operating as the trading name of Rokshaw Limited within EMMAC Life Sciences Group. It supplies UK-manufactured and imported cannabis oils and dried flower via the Cooper patient portal and tracked courier delivery.
- Company typePrivate
- Founded2018
- HeadquartersSunderland, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Curaleaf Pharmacy does
Curaleaf Pharmacy (trading name of Rokshaw Limited, company number 8154114) is a GPhC-registered online pharmacy specializing in the dispensing and home delivery of medical cannabis prescriptions to private patients across the UK and Channel Islands. Founded in 2018 following UK legalisation of cannabis-based products for medicinal use, and rebranded from CBPM Access Pharmacy to Curaleaf Pharmacy in April 2022, the company operates from registered premises in Sunderland under Superintendent Pharmacist Adam Foster (GPhC number 2065540). The company is part of EMMAC Life Sciences Group, which controls the full supply chain through affiliated Rokshaw Laboratories, an MHRA-regulated specials manufacturer producing EU GMP-compliant medical cannabis.
The product offering is organized into two ranges: a UK-manufactured range (oils and dried flower) produced in MHRA-approved facilities with over a decade of manufacturing experience, and an imported range featuring products from suppliers including Althea, Tilray, and Khiron. Medical cannabis is dispensed as oils (sublingual administration) or dried flower (vaporisation), in CBD-dominant and THC-containing formulations. The core technology platform is Cooper, a patient portal launched in March 2023 and fully operational by June 2023, which enables end-to-end prescription management including secure payment processing, prescription splitting, order tracking, courier tracking, delivery method selection, prescription and payment history, and live chat support.
The business model is private-pay prescription dispensing on a transaction-fee basis, with monthly 28-day supply cycles and pricing that varies by product type, formulation, and quantity (not publicly disclosed on the website). Go-to-market combines direct-to-consumer patient acquisition via website, social media, and email with a sales-led clinic partnership channel where specialist prescriber clinics (Curaleaf Clinic, Sapphire Clinics) refer patients for dispensing. Delivery is handled via tracked courier service with PIN verification. Revenue is not publicly disclosed, but the company states it fulfills thousands of patient prescriptions each month. The business is privately held within EMMAC Life Sciences Group with no external venture or private equity investment disclosed.
Curaleaf Pharmacy firmographics
Firmographics- Name
- Curaleaf Pharmacy
- Legal name
- Rokshaw Limited
- Website
- https://curaleafpharmacy.co.uk
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Curaleaf Pharmacy is a GPhC-registered online pharmacy dispensing private medical cannabis prescriptions to UK and Channel Islands patients, operating as the trading name of Rokshaw Limited within EMMAC Life Sciences Group. It supplies UK-manufactured and imported cannabis oils and dried flower via the Cooper patient portal and tracked courier delivery.
- Ownership category
- akta.pro rank
Curaleaf Pharmacy industry classification
Industry- Product category
- Medical Cannabis Pharmacy Services
- NAICS
- Pharmacies and Drug Retailers (45611)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Medical Cannabis Delivery & Online Ordering (CRANAGAG), Pharmacy & Health Essentials Delivery (CRAFAFAI)
Keywords
Where Curaleaf Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Sunderland
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Curaleaf Pharmacy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Cannabis Prescription Dispensing: Private pharmacy dispensing medical cannabis prescriptions. Patients pay for their medication as a private prescription. Monthly supply based on 28-day prescription cycles. Payment processed through secure online payment gateway.
- Clinic Partnership Services: Processing medical cannabis prescriptions for patients referred from specialist prescriber clinics. Works with clinics to ensure consistent and sustainable treatment in terms of product quality, service and price.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Private prescription pricing - variable based on product and quantity |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Curaleaf Pharmacy product offering
Product offeringCore offering
Curaleaf Pharmacy is a GPhC-registered online pharmacy that dispenses private medical cannabis prescriptions to patients across the UK and Channel Islands. It supplies UK-manufactured (EU GMP, MHRA-regulated via Rokshaw Laboratories) and imported medical cannabis products in oil and dried flower formats, delivered through a tracked courier service. Patients access and manage their prescriptions, payments, and repeat orders through the proprietary Cooper Patient Portal.
Product overview
Curaleaf Pharmacy is a GPhC-regulated online pharmacy specialising in medical cannabis dispensing. The core offering centres on the Cooper Patient Portal, an online ordering system enabling patients to manage prescriptions from order through delivery with features including secure payment, prescription splitting, live chat, and courier tracking. The pharmacy dispenses two main product categories: UK-manufactured medical cannabis (oils and dried flower) produced to EU GMP standards in MHRA-approved facilities, and imported medical cannabis products from international suppliers (Althea, Tilray, Khiron). Medical cannabis is available as oil (sublingual administration) or dried flower (vaporisation), with both CBD-dominant and THC-containing formulations. Complimentary prescription delivery service provides tracked courier delivery across the UK and Channel Islands.
Differentiator
Problem solved
Functional benefit
Products and services
- Cooper Patient Portal Online ordering portal that lets patients manage prescriptions through the entire journey: secure payment gateway, prescription splitting/adjustment, order and courier tracking, previous prescription and payment history, delivery method selection, and live chat support.
- Medical Cannabis Oil Cannabis oil products containing THC and/or CBD, taken sublingually using an oral syringe for accurate dosing, providing longer background treatment of symptoms for patients with a valid specialist prescription.
- Dried Medical Cannabis Flower Dried cannabis flower supplied as flos (ungrounded buds) or granulate (pre-grounded) for use with a vaporiser device, providing fast symptom relief; heat activation at 180°C releases active cannabinoids.
- UK Manufactured Medical Cannabis Range Medical cannabis products manufactured in the UK by MHRA-approved Rokshaw Laboratories to EU GMP standards, available in various strengths and formulations of CBD and THC, bespoke to individual patient requirements with consistent strain assurance.
- Imported Medical Cannabis Range Imported medical cannabis products sourced from international suppliers including Althea, Tilray, and Khiron, with capability to source alternative brands through an extensive supply network.
- Prescription Delivery Service Tracked courier delivery service across the UK and Channel Islands with next-day delivery once payment and prescription are received; deliveries require signature and PIN confirmation for secure medication handover.
Quantifiable outcome
- Next day delivery available once prescription and payment received
- +1 more outcomes
Companies that use Curaleaf Pharmacy
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Curaleaf Pharmacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability2 records
Feature3 records
Curaleaf Pharmacy partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Rokshaw LaboratoriescoreProducts are made and supplied from pharmaceutical sister company Rokshaw Laboratories, which is regulated by the MHRA. Rokshaw is a specials manufacturer with over 10 years experience, ensuring medical cannabis imported or produced is high quality. Curaleaf Pharmacy is the trading name of Rokshaw Ltd.
- Curaleaf CliniccoreCuraleaf Pharmacy works with specialist prescriber clinic Curaleaf Clinic to help patients get appointments with specialist prescribers. Curaleaf Clinic offers potentially free repeat prescriptions and reduced appointment prices to help reduce overall costs for patients.
- EMMAC Life Sciences GroupcoreAs part of EMMAC Life Sciences group, Curaleaf Pharmacy controls entire supply chain from cultivation, extraction and manufacture to ensure highest level of product quality and service standards.
- Sapphire ClinicscoreMedical cannabis specialist clinic offering patient referrals and accepting patient self-referrals. Part of shared care network for prescription processing and patient management.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
Curaleaf Pharmacy competitors and assessment
Company assessmentDirect peers
- Specialist Pharmacy (formerly Grow Pharma): UK-based importer and distributor of medical cannabis with associated pharmacy dispensing services. Directly comparable in UK medical cannabis pharmacy operations, EU GMP product focus, and clinic partnerships.
- IPS Pharma: UK GPhC-registered pharmacy specialising in dispensing medical cannabis prescriptions. Directly comparable as a specialist cannabis pharmacy serving private patients in the UK with home delivery and clinic partnerships.
- Mamedica: UK-based medical cannabis clinic and pharmacy that dispenses private prescriptions for cannabis-based medicines. Directly comparable in terms of target patients (private UK cannabis patients), specialist prescriber model, and pharmacy-led dispensing approach.
- MCTC (Medical Cannabis Clinics): UK specialist medical cannabis clinic network that operates its own dispensing pharmacy arm. Comparable in serving private medical cannabis patients, partnering with prescribers, and providing direct-to-patient delivery.
- Lyphe Group (Lyphe Dispensary): UK medical cannabis group integrating specialist clinics and a pharmacy dispensary. Directly comparable through its vertically integrated UK clinic-to-pharmacy model and private prescription dispensing.
Emerging players
- Sapphire Medical Clinics: UK medical cannabis clinic that both prescribes and dispenses cannabis-based medicines. Comparable as a UK specialist prescriber-clinic operator with pharmacy functions and overlapping patient base.
Broad incumbents
- Rowlands Pharmacy: UK-wide pharmacy chain offering prescription dispensing services. Comparable as a UK GPhC-registered pharmacy dispensing private prescriptions, though operating from physical branches with a broader non-cannabis focus.
- Phlo: UK-based digital pharmacy offering prescription management and delivery. Comparable in the online pharmacy / direct-to-patient prescription fulfilment model, though not a cannabis specialist.
- LloydsPharmacy (Online Doctor): Major UK pharmacy chain operating an online doctor and dispensing service. Comparable as a regulated UK pharmacy serving private prescriptions with home delivery, though broader in scope than cannabis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Curaleaf Pharmacy social profiles
Digital presenceCuraleaf Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curaleaf Pharmacy leadership team
Management profileNumber of profiles
Profiles1 record
Curaleaf Pharmacy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curaleaf Pharmacy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curaleaf Pharmacy
What does Curaleaf Pharmacy do?
Curaleaf Pharmacy is a GPhC-registered online pharmacy that dispenses private medical cannabis prescriptions to patients across the UK and Channel Islands. It supplies UK-manufactured (EU GMP, MHRA-regulated via Rokshaw Laboratories) and imported medical cannabis products in oil and dried flower formats, delivered through a tracked courier service. Patients access and manage their prescriptions, payments, and repeat orders through the proprietary Cooper Patient Portal.
Is Curaleaf Pharmacy a public or private company?
Curaleaf Pharmacy is a private company. It is classified as corporate owned and is currently operating.
When was Curaleaf Pharmacy founded?
Curaleaf Pharmacy was founded in 2018. It employs 11 to 50 people.
Where is Curaleaf Pharmacy based?
Curaleaf Pharmacy is headquartered in Sunderland, United Kingdom, in the Europe region.
How does Curaleaf Pharmacy make money?
Two revenue lines are on record. Medical Cannabis Prescription Dispensing is the primary driver. The others are clinic Partnership Services.
Who are Curaleaf Pharmacy's main competitors?
Direct peers on record are Specialist Pharmacy (formerly Grow Pharma), IPS Pharma, Mamedica, MCTC (Medical Cannabis Clinics) and Lyphe Group (Lyphe Dispensary). Sapphire Medical Clinics is listed as an emerging player. Broad incumbents are Rowlands Pharmacy, Phlo and LloydsPharmacy (Online Doctor).
Does Curaleaf Pharmacy have an API?
No public API is recorded for Curaleaf Pharmacy.
What industry is Curaleaf Pharmacy in?
Curaleaf Pharmacy's product category is Medical Cannabis Pharmacy Services. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 45611 and its SIC code is 5912.